1. Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India
- Author
-
Sham Santhanam, Himanshu Pathak, Pravin P. Patil, Somya Jain, Mohit Goyal, Nilesh Nolkha, Shashank Akerkar, Rahul Jain, B. D. Pandey, Naval Mendiratta, Durga Prasanna Misra, Akshat Pandey, P. Das, Bharat K Singh, Ashish Sharma, Sharath Kumar, Vishnu Sharma, Shriyanka Jain, Nikhil Gupta, A.K. Goel, Rajkiran Dudam, and Mithun Cb
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Immunology ,India ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tocilizumab ,Rheumatology ,Internal medicine ,Pandemic ,medicine ,Humans ,Lupus Erythematosus, Systemic ,Immunology and Allergy ,skin and connective tissue diseases ,Pandemics ,030203 arthritis & rheumatology ,SARS-CoV-2 ,Septic shock ,business.industry ,COVID-19 ,Hydroxychloroquine ,medicine.disease ,Pneumonia ,Venous thrombosis ,030104 developmental biology ,chemistry ,business ,medicine.drug - Abstract
We have read the recent report by Mathian et al with great interest where they described the clinical course of COVID-19 in 17 patients with systemic lupus erythematosus (SLE).1 The COVID-19 pandemic has caught the attention of the rheumatology fraternity due to a variety of reasons, such as the in vitro inhibition of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by hydroxychloroquine (HCQ),2 use of tocilizumab in the treatment of cytokine storm3 and concerns regarding cardiac toxicity due to HCQ.4 Patients with SLE are routinely prescribed HCQ and other immunosuppressants. The clinical picture of COVID-19 (such as pneumonia, cardiac injury, renal injury, venous thrombosis and septic shock) in patients with SLE on long-term HCQ described by Mathian et al intrigued the global rheumatology community.1 We assessed the impact of the pandemic on Indian patients with SLE in a larger multicentric survey. We expected that differences in disease expression, ethnicity and treatment may possibly alter the impact of the pandemic in contrast to the aforementioned study. We included patients who had visited their …
- Published
- 2020